These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24004586)

  • 1. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
    YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.
    Peuchmaur M; d'Amore ES; Joshi VV; Hata J; Roald B; Dehner LP; Gerbing RB; Stram DO; Lukens JN; Matthay KK; Shimada H
    Cancer; 2003 Nov; 98(10):2274-81. PubMed ID: 14601099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathology of peripheral neuroblastic tumors].
    Wang L; He LJ; Shimada H
    Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):283-8. PubMed ID: 22800533
    [No Abstract]   [Full Text] [Related]  

  • 8. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
    Umehara S; Nakagawa A; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Shimada H
    Cancer; 2000 Sep; 89(5):1150-61. PubMed ID: 10964346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral neuroblastic tumors: anatomo pathological classification].
    Peuchmaur M
    Ann Pathol; 2004 Dec; 24(6):556-67. PubMed ID: 15785402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed.
    Decarolis B; Simon T; Krug B; Leuschner I; Vokuhl C; Kaatsch P; von Schweinitz D; Klingebiel T; Mueller I; Schweigerer L; Berthold F; Hero B
    BMC Cancer; 2016 Jul; 16():542. PubMed ID: 27465021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
    Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological features of neuroblastic tumors: A comparison of neuroblastoma and ganglioneuroblastoma.
    He WG; Yan Y; Tang W; Cai R; Ren G
    Oncotarget; 2017 Jun; 8(23):37730-37739. PubMed ID: 28465480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and surgical outcome differences on the basis of pathology category in cervical neuroblastic tumors.
    Liu Q; Wang S; Chu P; Sun J; Jin Y; Guo Y; Ma X; He L; Su Y; Zhang J; Peng Y; Li Y; Zhang X; Sun N; Liu Z; Ni X
    J Pediatr Surg; 2022 Dec; 57(12):926-933. PubMed ID: 35961818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
    Tornóczky T; Kálmán E; Kajtár PG; Nyári T; Pearson AD; Tweddle DA; Board J; Shimada H
    Cancer; 2004 Jan; 100(2):390-7. PubMed ID: 14716776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLUT1 protein expression correlates with unfavourable histologic category and high risk in patients with neuroblastic tumours.
    Ramani P; Headford A; May MT
    Virchows Arch; 2013 Feb; 462(2):203-9. PubMed ID: 23307190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
    Wen Y; Peng Y; Duan XM; Zhang N
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
    Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
    Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of cell proliferation in human neuroblastoma: comparison with other prognostic factors.
    Mejía C; Navarro S; Pellín A; Ruíz A; Castel V; Llombart-Bosch A
    Oncol Rep; 2003; 10(1):243-7. PubMed ID: 12469176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.